Signal Transduction and Targeted Therapy
信號轉(zhuǎn)導和靶向治療
- 影響因子：5.873
中文簡介
信號轉(zhuǎn)導與靶向治療(ISSN 2059-3635 (online)， ISSN 2095-9907 (print)， CN 51-1758/R)是一份開放獲取的期刊，旨在及時發(fā)表與信號轉(zhuǎn)導和靶向治療相關的基礎科學和臨床研究的最新發(fā)現(xiàn)和進展。它將包括對主要人類疾病的研究，如癌癥、自身免疫性疾病等。
英文簡介
Signal Transduction and Targeted Therapy (ISSN 2059-3635 (online), ISSN 2095-9907 (print), CN 51-1758/R) is an open access journal, which aims to accomplish timely publication of the latest discoveries and progress in both basic science and clinical research related to signal transduction and targeted therapy. It will include research on major human diseases, such as cancer, autoimmune disorders and others.
近年期刊自引率趨勢圖
JCR分區(qū)
| JCR分區(qū)等級 | JCR所屬學科 | 分區(qū) | 影響因子 |
| Q1 | CELL BIOLOGY | Q1 | 38.104 |
| BIOCHEMISTRY & MOLECULAR BIOLOGY | Q1 |
近年期刊影響因子趨勢圖
CiteScore數(shù)值
| CiteScore | SJR | SNIP | 學科類別 | 分區(qū) | 排名 | 百分位 |
| 18.40 | 5.157 | 3.979 | 大類：Biochemistry, Genetics and Molecular Biology 小類：Genetics | Q1 | 11 / 335 |
96% |
| 大類：Biochemistry, Genetics and Molecular Biology 小類：Cancer Research | Q1 | 13 / 210 |
94% |
